Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain

Human Psychopharmacology

Volumn 28, Issue 2, 2013, Pages 183-187

  Brandl, Eva J ^a   Tiwari, Arun K ^a   Lett, Tristram A ^a   Shaikh, Sajid A ^a   Lieberman, Jeffrey A ^b   Meltzer, Herbert Y ^c   Kennedy, James L ^a   Müller, Daniel J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

antipsychotic induced weight gain; clozapine; glucose metabolism; olanzapine; pharmacogenetics; TBC1D1

Indexed keywords

CLOZAPINE; MICRORNA; OLANZAPINE; RAB PROTEIN; TBC1 DOMAIN FAMILY MEMBER 1 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BODY WEIGHT; DEPENDENT VARIABLE; DISEASE DURATION; EXPLORATORY RESEARCH; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GTPASE-ACTIVATING PROTEINS; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 84875681266     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2288     Document Type: Article

References (40)

1. Albaugh VL, Singareddy R, Mauger D, Lynch CJ,. 2011. A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers. PLoS One 6: e22662.
2. An D, Toyoda T, Taylor EB, et al,. 2010. TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle. Diabetes 59: 1358-1365.
3. Balt SL, Galloway GP, Baggott MJ, Schwartz Z, Mendelson J,. 2011. Mechanisms and genetics of antipsychotic-associated weight gain. Clin Pharmacol Ther 90: 179-183.
4. Barrett JC, Fry B, Maller J, Daly MJ,. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
5. Bartel DP,. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
6. Bogan JS,. 2012. Regulation of glucose transporter translocation in health and diabetes. Annu Rev Biochem 81: 507-532.
7. Brandl EJ, Frydrychowicz C, Tiwari AK, et al,. 2012. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain. Prog Neuropsychopharmacol Biol Psychiatry 38: 134-141.
8. Chadt A, Leicht K, Deshmukh A, et al,. 2008. Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat Genet 40: 1354-1359.
9. Cooper GD, Pickavance LC, Wilding JP, Halford JC, Goudie AJ,. 2005. A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl) 181: 80-89.
10. Fontanesi L, Colombo M, Tognazzi L, et al,. 2011. The porcine TBC1D1 gene: mapping, SNP identification, and association study with meat, carcass and production traits in Italian heavy pigs. Mol Biol Rep 38: 1425-1431.
11. Fontanesi L, Galimberti G, Calo DG, et al,. 2012. Identification and association analysis of several hundred single nucleotide polymorphisms within candidate genes for backfat thickness in Italian Large White pigs using a selective genotyping approach. J Anim Sci 90: 2450-2464.
12. Gauderman WJ, Morrison JM,. 2006. A computer program for power and sample size calculations for genetic-epidemiology studies. [Online]. Available: http://hydra.usc.edu.gxe.
13. Henderson DC, Cagliero E, Copeland PM, et al,. 2005. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 62: 19-28.
14. Herrera BM, Lockstone HE, Taylor JM, et al,. 2009. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes. BMC Med Genomics 2: 54.
15. Jassim G, Skrede S, Vazquez MJ, et al,. 2012. Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology (Berl) 219: 783-794.
16. Jessen N, An D, Lihn AS, et al,. 2011. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164-E171.
17. Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH,. 2007. From the Cover: antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci USA 104: 3456-3459.
18. Kim JH, Lee JO, Lee SK, et al,. 2010. Clozapine activates AMP-activated protein kinase (AMPK) in C2C12 myotube cells and stimulates glucose uptake. Life Sci 87: 42-48.
19. Lahiri DK, Nurnberger JI, Jr., 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19: 5444.
20. Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Muller DJ,. 2012. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 17: 242-266.
21. Meyre D, Farge M, Lecoeur C, et al,. 2008. R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population. Hum Mol Genet 17: 1798-1802.
22. Newcomer JW, Haupt DW, Fucetola R, et al,. 2002. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 59: 337-345.
23. Peck GR, Chavez JA, Roach WG, et al,. 2009. Insulin-stimulated phosphorylation of the Rab GTPase-activating protein TBC1D1 regulates GLUT4 translocation. J Biol Chem 284: 30016-30023.
24. Roerig JL, Steffen KJ, Mitchell JE,. 2011. Atypical antipsychotic-induced weight gain: insights into mechanisms of action. CNS Drugs 25: 1035-1059.
25. Sajatovic M, Jenkins JH,. 2007. Is antipsychotic medication stigmatizing for people with mental illness? Int Rev Psychiatry 19: 107-112.
26. Smith RC, Lindenmayer JP, Davis JM, et al,. 2009. Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study. J Clin Psychiatry 70: 1501-1513.
27. Souza RP, Tiwari AK, Chowdhury NI, et al,. 2012. Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain. J Psychiatr Res 46: 462-468.
28. Stone S, Abkevich V, Russell DL, et al,. 2006. TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Hum Mol Genet 15: 2709-2720.
29. Szekeres F, Chadt A, Tom RZ, et al,. 2012. The Rab-GTPase activating protein TBC1D1 regulates skeletal muscle glucose metabolism. Am J Physiol Endocrinol Metab 303: E524-533.
30. Taylor EB, An D, Kramer HF, et al,. 2008. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J Biol Chem 283: 9787-9796.
31. Tiwari AK, Rodgers JB, Sicard M, et al,. 2010a. Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 34: 1484-1490.
32. Tiwari AK, Zai CC, Meltzer HY, Lieberman JA, Muller DJ, Kennedy JL,. 2010b. Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients. Hum Psychopharmacol 25: 253-259.
33. Tulipano G, Rizzetti C, Bianchi I, Fanzani A, Spano P, Cocchi D,. 2007. Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation. Neuroendocrinology 85: 61-70.
34. Tulipano G, Spano P, Cocchi D,. 2008. Effects of olanzapine on glucose transport, proliferation and survival in C2C12 myoblasts. Mol Cell Endocrinol 292: 42-49.
35. Veselinovic T, Himmerich H,. 2010. Antihistaminergic antipsychotics cause weight gain. Nervenarzt 81: 329-334.
36. Vestri HS, Maianu L, Moellering DR, Garvey WT,. 2007. Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacology 32: 765-772.
37. Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L, Natarajan R,. 2010. Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 59: 2904-2915.
38. Wang M, Tong JH, Zhu G, Liang GM, Yan HF, Wang XZ,. 2012. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study. Schizophr Res 138: 54-57.
39. Wu RR, Zhao JP, Guo XF, et al,. 2008a. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Am J Psychiatry 165: 352-358.
40. Wu RR, Zhao JP, Jin H, et al,. 2008b. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 299: 185-193.